Found vs PlexusDx: GLP-1 Pricing and Payment Structures Compared

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found's cash-pay program charges $289 per month for compounded semaglutide on a rolling monthly plan (billed every four weeks, resulting in 13 charges per year), or $169 per month when you prepay $2,028 upfront for a full year. PlexusDx charges $189 per month on a month-to-month basis with no prepayment, $169 per month on a three-month plan, or $149 per month on a six-month plan. Over twelve calendar months, PlexusDx month-to-month totals $2,268 versus $3,757 for Found's monthly plan; Found's 12-month prepaid total of $2,028 sits $240 below PlexusDx month-to-month and $240 above PlexusDx six-month ($1,788). For tirzepatide, Found charges $359 monthly or $239 per month prepaid annually ($2,868 total), while PlexusDx charges $289 month-to-month ($3,468 annually) or $249 per month on six-month terms ($2,988 annually). The lower headline rate at Found requires full upfront payment and a 12-month commitment; PlexusDx offers lower or comparable rates without prepayment, depending on the plan length you choose.

At-a-glance comparison

Sources: Found pricing captured from joinfound.com/plans-and-pricing July 20, 2026 and September 4, 2026; PlexusDx pricing captured from plexusdx.com comparison pages and checkout flow July 20, 2026 and September 4, 2026; Trustpilot ratings captured September 4, 2026.

Normalized 12-month pricing: semaglutide

Found's monthly semaglutide plan charges $289 every four weeks—13 billing cycles per year—for an annual total of $3,757 (our calculation: $289 × 13). Divided across twelve calendar months, that works out to $313 per month. Found's 12-month prepaid plan requires $2,028 upfront and yields a $169 per-month equivalent over the year, saving $1,729 compared to the rolling monthly plan (our calculation: $3,757 − $2,028).

PlexusDx charges $189 per month on a month-to-month basis with calendar-month billing (twelve charges per year), totaling $2,268 annually (our calculation: $189 × 12). The three-month plan drops the rate to $169 per month ($2,028 annually, our calculation), and the six-month plan lands at $149 per month ($1,788 annually, our calculation). PlexusDx does not offer a 12-month plan.

Comparing Found's rolling monthly rate to PlexusDx month-to-month, PlexusDx is $1,489 lower over twelve months (our calculation: $3,757 − $2,268), or $100 per month lower. Comparing Found's 12-month prepaid plan ($2,028) to PlexusDx month-to-month ($2,268), Found's annual plan is $240 lower. Comparing Found's 12-month prepaid plan to PlexusDx six-month ($1,788), PlexusDx six-month is $240 lower (our calculation: $2,028 − $1,788).

Normalized 12-month pricing: tirzepatide

Found's monthly tirzepatide plan charges $359 every four weeks (13 cycles annually), totaling $4,667 (our calculation: $359 × 13), or $389 per calendar month. The 12-month prepaid plan costs $2,868 upfront ($239 per month equivalent), saving $1,799 versus the monthly plan (our calculation: $4,667 − $2,868).

PlexusDx charges $289 per month month-to-month for tirzepatide injection ($3,468 annually, our calculation: $289 × 12), or $249 per month on a six-month plan ($2,988 annually, our calculation: $249 × 12).

PlexusDx month-to-month is $1,199 lower than Found's monthly plan over twelve months (our calculation: $4,667 − $3,468), or $70 per month lower. PlexusDx month-to-month totals $600 higher than Found's 12-month prepaid plan (our calculation: $3,468 − $2,868). PlexusDx six-month totals $120 higher than Found's 12-month prepaid plan (our calculation: $2,988 − $2,868).

The every-four-weeks billing model

Found bills monthly plans every four weeks rather than on calendar months. Over a standard 52-week year, that produces 13 billing events instead of 12. A $289 charge repeated 13 times totals $3,757—not $3,468—and an effective calendar-month rate of $313, not $289. This structure means Found's advertised monthly rate understates the annual cost unless you account for the extra cycle. PlexusDx and most competing programs bill on calendar months (twelve cycles per year), so a stated $189 per month produces an annual cost of exactly $2,268.

When comparing advertised monthly rates, confirm the billing cadence. A lower per-cycle figure on a four-week schedule can produce a higher annual total than a slightly higher figure billed monthly.

Prepayment: who holds the savings, who holds the risk

Found's 12-month plans deliver the lowest per-month rate in this comparison for both semaglutide ($169) and tirzepatide ($239), but they require full payment upfront: $2,028 for semaglutide, $2,868 for tirzepatide (captured September 4, 2026 from joinfound.com/plans-and-pricing). If you discontinue treatment early—whether due to side effects, goal achievement, or cost—you have prepaid for months you will not use. Found states that plans can be canceled anytime in the app (captured July 20, 2026), but the evidence reviewed does not specify whether unused months are refunded pro rata or forfeited. Confirm the refund policy at checkout before prepaying.

PlexusDx month-to-month plans carry no upfront commitment; you pay $189 (semaglutide) or $289 (tirzepatide) in the month you use the medication, and you can stop without forfeiting prepaid funds. The three-month and six-month PlexusDx plans require payment for the full term at the start—$507 upfront for three months of semaglutide at $169/month (our calculation: $169 × 3), or $894 upfront for six months at $149/month (our calculation: $149 × 6)—but the financial exposure is smaller than Found's 12-month lock-in.

If you are confident you will stay on treatment for a full year and can afford the upfront outlay, Found's annual plan offers a lower total cost than PlexusDx month-to-month for semaglutide ($2,028 vs. $2,268) and tirzepatide ($2,868 vs. $3,468). If you prefer monthly flexibility or cannot prepay, PlexusDx month-to-month totals less than Found's rolling monthly plan by $1,489 (semaglutide) or $1,199 (tirzepatide) over twelve months.

Insurance versus cash-pay at Found

Found operates two distinct tracks: a cash-pay program (the focus of this comparison) and an insurance-supported program. The insurance track charges $99 per month when you prepay $1,188 for a 12-month plan, or $199 per month on a rolling monthly basis, plus your plan's medication copay—typically around $30 for compounded GLP-1s (captured September 4, 2026 from joinfound.com/plans-and-pricing). Branded medications (Ozempic, Wegovy, Zepbound, Mounjaro) are billed separately and subject to insurance formulary and prior authorization; costs vary widely.

If your insurance covers compounded GLP-1 prescriptions and you qualify for Found's insurance track, the effective monthly cost can be substantially lower than either cash-pay program discussed here. PlexusDx does not accept insurance; all pricing is cash-pay. If insurance coverage is available to you, compare Found's insurance track total (membership plus copay) against PlexusDx cash rates before deciding.

Medication options and format

Found's cash-pay program includes compounded semaglutide injection and compounded tirzepatide injection. The company also references Foundayo, an oral medication (orforglipron), though pricing and availability for that option were not detailed in the sources reviewed (captured September 4, 2026). Branded GLP-1s are available through Found's insurance track but are billed separately from the plan price.

PlexusDx offers compounded semaglutide and tirzepatide in both injectable and oral capsule forms. Injectable semaglutide is $189 per month month-to-month, oral semaglutide is $289 per month, injectable tirzepatide is $289 per month, and oral tirzepatide is $349 per month (month-to-month rates, captured July 20, 2026). PlexusDx also offers a microdose GLP-1 injectable protocol at $129 per month for maintenance or initial titration (captured July 20, 2026). The oral capsule route may appeal to patients who prefer to avoid injections, though the evidence reviewed does not provide head-to-head bioavailability or efficacy data for oral versus injectable compounded formulations.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Included services and technology

Found includes licensed clinician access, a personalized care plan, healthy habits guidance, the Aimee AI concierge, 24/7 access to a care team, and the Found app (captured July 20, 2026 and September 4, 2026). The Aimee AI feature is positioned as a conversational assistant for questions and accountability between clinician visits, though user experience and response quality were not evaluated in the evidence reviewed.

PlexusDx includes a licensed provider review of your intake, medication if approved, shipping, and a complimentary PharmD check-in after your first order. An optional genetic-response analysis add-on is available at $99 for members (standalone price $298, captured July 20, 2026) to assess genetic factors that may influence GLP-1 response or side-effect risk. PlexusDx does not offer a dedicated app or 24/7 chat support in the evidence reviewed.

If ongoing coaching, app-based tracking, or round-the-clock messaging access are priorities, Found's service bundle may justify the higher rolling monthly cost. If you prefer a streamlined clinical model with optional genetic insight and lower monthly outlay, PlexusDx delivers medication and provider oversight without the added technology layer.

HSA and FSA eligibility

Found states that its cash-pay plans are HSA/FSA eligible (captured July 20, 2026). PlexusDx pricing similarly qualifies as a medical expense, and most compounded GLP-1 prescriptions are reimbursable through health savings or flexible spending accounts, but confirm with your plan administrator before assuming coverage. Neither program files insurance claims or provides superbills automatically in the evidence reviewed; you may need to request an itemized receipt for reimbursement.

Trustpilot ratings and reported experience

Found holds a 4.1-star rating on Trustpilot with approximately 732 reviews (captured September 4, 2026). PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Both programs show majority-positive feedback. The evidence reviewed did not include coded negative themes for Found, and no service-quality complaints were systematically captured for either program in the research packet. Individual experiences vary, and review sentiment can shift; consult current reviews on Trustpilot or Reddit before committing to a long-term prepaid plan.

Choose Found if…

• You are confident you will remain on GLP-1 therapy for a full year and want the lowest per-month rate available in this comparison: $169 for semaglutide or $239 for tirzepatide.
• You can afford to prepay $2,028 (semaglutide) or $2,868 (tirzepatide) upfront and accept the financial risk if you discontinue early.
• You value integrated coaching, app-based tracking, AI-assisted support, and 24/7 care-team access as part of your monthly fee.
• You have insurance that covers compounded GLP-1 prescriptions and qualify for Found's insurance track, which can reduce your effective cost to $99–$199 per month plus copay.

Choose PlexusDx if…

• You prefer month-to-month flexibility with no upfront financial commitment and want to pay only for the months you use medication.
• You want a lower rolling monthly cost than Found's four-week billing plan: $189 vs. $289 for semaglutide (saving $1,489 over twelve months), or $289 vs. $359 for tirzepatide (saving $1,199 over twelve months).
• You are willing to prepay for three or six months to secure a rate ($169 or $149 per month for semaglutide, $269 or $249 for tirzepatide) that rivals or beats Found's 12-month rate without the full-year lock-in.
• You are interested in oral GLP-1 capsules, microdose protocols, or genetic-response testing to tailor your regimen.
• You do not need app-based coaching or AI concierge features and prefer a streamlined clinical service with transparent per-month pricing.

Methodology and freshness

Pricing and service details for Found were captured from joinfound.com/plans-and-pricing on July 20, 2026 and verified September 4, 2026. PlexusDx pricing was captured from plexusdx.com comparison pages and checkout flows on July 20, 2026 and verified September 4, 2026. Trustpilot ratings were captured September 4, 2026. All annual totals, effective monthly rates, and savings figures labeled "our calculation" were derived by multiplying stated per-cycle rates by the number of billing events per year (13 for Found's four-week plans, 12 for calendar-month plans) or by the term length for prepaid multi-month plans. Compounded-medication regulatory status is stated verbatim per FDA guidance. This comparison reflects evidence available as of the capture dates cited; confirm current pricing, billing terms, refund policies, and medication availability at checkout before committing to any plan.

Frequently Asked Questions

Does Found's $169-per-month semaglutide rate require upfront payment?

Yes. Found's $169-per-month rate is the per-month equivalent of a 12-month prepaid plan that costs $2,028 upfront. The rolling monthly plan charges $289 every four weeks with no prepayment. Confirm the refund policy for unused months before prepaying.

Why does Found's monthly plan cost more annually than the advertised rate suggests?

Found bills every four weeks rather than on calendar months, producing 13 billing cycles per year instead of 12. A $289 charge repeated 13 times totals $3,757 annually, or an effective $313 per calendar month. The advertised $289 rate is accurate per cycle but understates the annual cost unless you account for the extra charge.

Can I use insurance with PlexusDx to lower my cost?

No. PlexusDx operates as a cash-pay service and does not bill insurance or accept coverage for compounded GLP-1 prescriptions. If your insurance covers GLP-1 therapy, compare Found's insurance track ($99–$199 per month plus copay) against PlexusDx cash rates to determine your lower net cost.

Which program offers a lower total cost for tirzepatide over twelve months?

Found's 12-month prepaid plan totals $2,868 for tirzepatide, the lowest in this comparison. PlexusDx month-to-month totals $3,468 and six-month totals $2,988. Found's rolling monthly plan totals $4,667. If you can prepay and commit to a full year, Found delivers the lowest cost; if you prefer monthly flexibility, PlexusDx month-to-month is $1,199 lower than Found's rolling plan.

Does PlexusDx offer the same app and coaching features as Found?

No. Found includes the Aimee AI concierge, 24/7 care-team messaging, and app-based habit tracking as part of the monthly fee. PlexusDx offers a provider review, medication, shipping, and a complimentary PharmD check-in, with optional genetic-response testing, but does not provide a dedicated app or round-the-clock chat support in the evidence reviewed.

Sources

• Found pricing and service details: joinfound.com/plans-and-pricing, captured July 20, 2026 and September 4, 2026.
• PlexusDx pricing and service details: plexusdx.com comparison pages and checkout flows, captured July 20, 2026 and September 4, 2026.
• Found company profile and medication options: internal research dataset, captured September 4, 2026.
• Trustpilot ratings for Found and PlexusDx: Trustpilot.com, captured September 4, 2026.
• FDA guidance on compounded medications: FDA.gov, accessed September 4, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.